特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
943617

免疫治療薬の世界市場:タイプ、治療範囲、エンドユーザー、地域別予測、およびCOVID-19の影響

Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type, by Therapeutic Area, by End-User and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
免疫治療薬の世界市場:タイプ、治療範囲、エンドユーザー、地域別予測、およびCOVID-19の影響
出版日: 2020年06月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の免疫治療薬市場は、2019年に約1,468億米ドルとなりました。同市場は、予測期間中(2020年~2027年)に11%を超える順調な成長率で拡大すると予測されています。従来の治療レジメンより増えている免疫治療薬の採用、がんや自己免疫・感染症の有病率上昇、モノクローナル抗体やバイオシミラーの需要増加は、予測期間中における同市場の成長の要因となっています。ただし、タイムラインの問題、副作用、製造の複雑さは、市場成長を抑制する主な要因です。

当レポートは世界の免疫治療薬市場について調査しており、市場機会や動向、成長要因および課題、タイプ・治療範囲・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場定義および範囲

第3章 市場力学

  • 市場の影響分析

第4章 業界分析

  • ポーターのファイブフォース分析
  • PEST分析
  • 投資採用モデル
  • アナリストの提言・結論

第5章 市場分析:タイプ別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • モノクローナル抗体
    • チェックポイント阻害剤
    • インターフェロン・インターロイキン
    • その他

第6章 市場分析:治療範囲別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
    • 自己免疫疾患・炎症性疾患
    • 感染症
    • その他

第7章 市場分析:エンドユーザー別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • 病院
    • クリニック
    • その他

第8章 市場分析:地域別

  • 市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他の地域

第9章 競合情報

  • 主な市場戦略
  • 企業プロファイル
    • Roche Holding AG
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Novartis International AG
    • Johnson & Johnson
    • Sanofi S.A.
    • GlaxoSmithKline plc
    • AbbVie Inc.
    • Amgen Inc.
    • C.H. Boehringer Sohn AG & Co.. KG

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Immunotherapy Drugs market, report scope
  • TABLE 2. Global Immunotherapy Drugs market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Immunotherapy Drugs market estimates & forecasts by Type 2017-2027 (USD Billion)
  • TABLE 4. Global Immunotherapy Drugs market estimates & forecasts by Therapeutic Area 2017-2027 (USD Billion)
  • TABLE 5. Global Immunotherapy Drugs market estimates & forecasts by End-User 2017-2027 (USD Billion)
  • TABLE 6. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 23. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 24. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 25. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 26. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 27. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 28. U.S. Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 29. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. Canada Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 33. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. UK Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 37. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. Germany Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 41. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. France Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 45. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. Spain Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 49. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. Italy Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 53. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. ROE Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 57. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 58. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 59. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. China Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 61. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 62. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 64. India Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 65. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 67. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 68. Japan Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 69. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 70. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 71. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 72. Australia Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 73. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 74. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 76. South Korea Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 77. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 78. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 79. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 80. ROPAC Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 81. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 82. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 83. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 84. Brazil Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 85. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 86. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 87. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 88. Mexico Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 89. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 90. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 91. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 92. ROLA Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 93. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 94. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 95. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 96. ROW Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 97. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 98. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 99. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 100. List of secondary sources, used in the study of global Immunotherapy Drugs market
  • TABLE 101. List of primary sources, used in the study of global Immunotherapy Drugs market
  • TABLE 102. Years considered for the study
  • TABLE 103. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Immunotherapy Drugs market, research methodology
  • FIG 2. Global Immunotherapy Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Immunotherapy Drugs market, key trends 2019
  • FIG 5. Global Immunotherapy Drugs market, growth prospects 2020-2027
  • FIG 6. Global Immunotherapy Drugs market, porters 5 force model
  • FIG 7. Global Immunotherapy Drugs market, pest analysis
  • FIG 8. Global Immunotherapy Drugs market, value chain analysis
  • FIG 9. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 18. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 19. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 20. Global Immunotherapy Drugs market, regional snapshot 2017 & 2027
  • FIG 21. North America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 22. Europe Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 23. Asia Pacific Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 24. Latin America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 25. Global Immunotherapy Drugs market, company market share analysis (2019)
目次

Title:
Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type (Monoclonal Antibodies, Checkpoint Inhibitors, Interferons & Interleukins and Other Immunotherapies), by Therapeutic Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases and Others), by End-User (Hospitals, Clinics and Others) and Regional Forecasts 2020-2027.

Global Immunotherapy Drugs Market is valued approximately USD 146.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11 % over the forecast period 2020-2027. Immunotherapy drugs are used to enhance the immunity of human body, the drug stimulates the immune system of the body and generate an immune response aiding the production of antibodies that are produced against antigen to kill the cancerous or tumor cells. Immunotherapy Drugs is being highly demanded for enhancing the immune system during the coronavirus pandemic across the world. Furthermore, cancer immunotherapy community is poised to contribute to the current fight against COVID-19. The increasing adoption of immunotherapy drugs over conventional treatment regimens, rising prevalence of cancer and autoimmune & infectious diseases and increasing demand for monoclonal antibodies and biosimilars are the few factors responsible for growth of the market over the forecast period. For instance: as per American Cancer Society, more than 15.5 million cancer cases were reported in January 2016. Later 1.7 million new cases diagnosed in 2018 at U.S. Moreover, the rising advancements in immunotherapy drugs and other strategic alliance by market key players will create a lucrative demand for this market. For instance: in April 2018, Europe based Roche Holdings AG launched monoclonal antibody atezolizumab used for the treatment of small cell lung cancer in India. Whereas, timeline issues, side-effects, and manufacturing complexities are the major factors restraining the growth of global Immunotherapy Drugs market during the forecast period.

The regional analysis of global Immunotherapy Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increasing prevalence of cancer and autoimmune diseases, rising demand for safer cancer therapies, increasing number of approvals from the FDA, and the introduction of favorable reimbursement policies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:

Roche Holding AG

Pfizer Inc.

Merck & Co., Inc.

Novartis International AG

Johnson & Johnson

Sanofi S.A.

GlaxoSmithKline plc

AbbVie Inc.

Amgen Inc.

C.H. Boehringer Sohn AG & Co.. KG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type:

Monoclonal Antibodies

Checkpoint Inhibitors

Interferons & Interleukins

Other Immunotherapies

by Therapeutic Area:

Cancer

Autoimmune & Inflammatory Diseases

Infectious Diseases

Others

By End-User:

Hospitals

Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Immunotherapy Drugs Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Immunotherapy Drugs Market, by Type, 2018-2027 (USD Billion)
    • 1.2.3. Immunotherapy Drugs Market, by Therapeutic Area, 2018-2027 (USD Billion)
    • 1.2.4. Immunotherapy Drugs Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Immunotherapy Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Immunotherapy Drugs Market Dynamics

  • 3.1. Immunotherapy Drugs Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Immunotherapy Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Immunotherapy Drugs Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Immunotherapy Drugs Market by Type, Performance - Potential Analysis
  • 5.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
  • 5.4. Immunotherapy Drugs Market, Sub Segment Analysis
    • 5.4.1. Monoclonal Antibodies
    • 5.4.2. Checkpoint Inhibitors
    • 5.4.3. Interferons & Interleukins
    • 5.4.4. Other Immunotherapies

Chapter 6. Global Immunotherapy Drugs Market, by Therapeutic Area

  • 6.1. Market Snapshot
  • 6.2. Global Immunotherapy Drugs Market by Therapeutic Area, Performance - Potential Analysis
  • 6.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Therapeutic Area 2017-2027 (USD Billion)
    • 6.3.1. Cancer
    • 6.3.2. Autoimmune & Inflammatory Diseases
    • 6.3.3. Infectious Diseases
    • 6.3.4. Others

Chapter 7. Global Immunotherapy Drugs Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Immunotherapy Drugs Market by End-User, Performance - Potential Analysis
  • 7.3. Global Immunotherapy Drugs Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 7.4. Immunotherapy Drugs Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Others

Chapter 8. Global Immunotherapy Drugs Market, Regional Analysis

  • 8.1. Immunotherapy Drugs Market, Regional Market Snapshot
  • 8.2. North America Immunotherapy Drugs Market
      • 8.2.1.1. U.S. Immunotherapy Drugs Market
      • 8.2.1.2. Type breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. Therapeutic Area breakdown estimates & forecasts, 2017-2027
      • 8.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Immunotherapy Drugs Market
  • 8.3. Europe Immunotherapy Drugs Market Snapshot
    • 8.3.1. U.K. Immunotherapy Drugs Market
    • 8.3.2. Germany Immunotherapy Drugs Market
    • 8.3.3. France Immunotherapy Drugs Market
    • 8.3.4. Spain Immunotherapy Drugs Market
    • 8.3.5. Italy Immunotherapy Drugs Market
    • 8.3.6. Rest of Europe Immunotherapy Drugs Market
  • 8.4. Asia-Pacific Immunotherapy Drugs Market Snapshot
    • 8.4.1. China Immunotherapy Drugs Market
    • 8.4.2. India Immunotherapy Drugs Market
    • 8.4.3. Japan Immunotherapy Drugs Market
    • 8.4.4. Australia Immunotherapy Drugs Market
    • 8.4.5. South Korea Immunotherapy Drugs Market
    • 8.4.6. Rest of Asia Pacific Immunotherapy Drugs Market
  • 8.5. Latin America Immunotherapy Drugs Market Snapshot
    • 8.5.1. Brazil Immunotherapy Drugs Market
    • 8.5.2. Mexico Immunotherapy Drugs Market
  • 8.6. Rest of The World Immunotherapy Drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Roche Holding AG
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Pfizer Inc.
    • 9.2.3. Merck & Co., Inc.
    • 9.2.4. Novartis International AG
    • 9.2.5. Johnson & Johnson
    • 9.2.6. Sanofi S.A.
    • 9.2.7. GlaxoSmithKline plc
    • 9.2.8. AbbVie Inc.
    • 9.2.9. Amgen Inc.
    • 9.2.10. C.H. Boehringer Sohn AG & Co.. KG

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.